![Karen Vousden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Vousden
Directeur/Bestuurslid bij
BRISTOL-MYERS SQUIBB COMPANY
Vermogen: 796 773 $ op 31-10-2026
Profiel
Dr. Karen H.
Vousden is an Independent Director at Bristol Myers Squibb Co., an Associate at National Academy of Sciences, a Council Member at European Molecular Biology Organization and a President at British Association for Cancer Research.
She is on the Board of Directors at Faeth Therapeutics, Inc. and Bristol Myers Squibb Co. Dr. Vousden was previously employed as a Co-Founder by Faeth Therapeutics LLC.
She also served on the board at The Beatson Institute For Cancer Research.
She received her doctorate degree from Queen Mary University of London.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 11-09-2026 | 42.631 ( 0,17% ) | 796 773 $ | 31-10-2026 | |
| 12-03-2026 | 0 ( -.--% ) | - $ | 31-10-2026 |
Actieve functies van Karen Vousden
| Bedrijven | Functie | Begin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Directeur/Bestuurslid | 01-01-2018 |
| FAETH THERAPEUTICS, INC. | Directeur/Bestuurslid | 11-09-2026 |
British Association for Cancer Research
 British Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as a charity for cancer research | President | - |
European Molecular Biology Organization | Corporate Officer/Principal | - |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
Eerdere bekende functies van Karen Vousden
| Bedrijven | Functie | Einde |
|---|---|---|
The Beatson Institute For Cancer Research
 The Beatson Institute For Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research institute | Directeur/Bestuurslid | 01-01-2016 |
Faeth Therapeutics, Inc.
 Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Oprichter | - |
Opleiding van Karen Vousden
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
86
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
European Molecular Biology Organization | |
British Association for Cancer Research
British Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as a charity for cancer research | Commercial Services |
The Beatson Institute For Cancer Research
The Beatson Institute For Cancer Research Miscellaneous Commercial ServicesCommercial Services Operates as cancer research institute | Commercial Services |
Queen Mary University of London
 Queen Mary University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Health Technology |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
